Eli Lilly has launched Manjaro (Tirzepatide) in India, a major step in addressing rising chronic diseases like obesity and diabetes. In this episode, hosts Vikas and Teena speak with David A. Ricks, CEO of Eli Lilly, and Winselow Tucker, President & GM India, about upcoming launches, competition, and the role of emerging markets. They also discuss strategic partnerships, political challenges like tariffs, and Eli Lilly’s commitment to funding innovation and advancing global healthcare.
